Treatment of cancer could become possible with adenovirus
[2018-04-19] An international team of researchers led by professor Niklas Arnberg at Umeå University, shows that adenovirus binds to a specific type of carbohydrate that is overexpressed on certain types of cancer cells. The discovery opens up new opportunities for the development of virus-based cancer therapy. The study is published in the latest issue of the scientific journal "Proceedings of the National Academy of Sciences of USA", PNAS April 19, 2018.
Adenovirus is a common virus that causes infectious diseases of the respiratory tract, eyes and gastrointestinal tract in humans and animals. Researchers at Umeå University study molecular mechanisms of infection in order to understand how adenovirus causes disease.
The researchers in Umeå, together with research groups from Germany, the UK and Hungary, have now discovered a new type of mechanism used by a rare adenovirus type to attack cells.
Read more: Treatment of cancer could become possible with adenovirus
Two ERC Advanced Grants which have recently been awarded by the European Research Council (ERC) have a close relation to MIMS.
[2018-04-17] MIMS proudly announces that Dr. Oliver Billker from the Wellcome Sanger Institute, Cambridge, UK, has been recruited as future director of MIMS. Dr. Oliver Billker is a distinguished expert in malaria parasite genomics. In October 2018, he will succeed the founding Director of MIMS, Professor Bernt Eric Uhlin, who has held the role since 2007.
[2018-03-02] A new paper published by the research groups of Gemma Atkinson and Vasili Hauryliuk at Umeå University resolves years of uncertainty about how the widespread antibiotic resistance factors in the protein group ABCF family confer resistance to lincosamide antibiotics, often used in treatment of infections caused by staphylococci, streptococci and anaerobic bacteria.
2018-03-02] Congratulations to Vasili Hauryliuk, who was honored with the National Research Award in Chemistry and Molecular Biology 2018 of the Republic of Estonia on 20th of February in Tartu. Hauryliuk was awarded as one of seven members of a research team at UT Institute of Technology led by Tanel Tenson, professor of the technology of antimicrobial compounds. The team was awarded for the cycle of research works, “Mechanisms of antibiotic action and antibiotic resistance”. The other members in the awarded research team are: Arvi Jõers, Niilo Kaldalu, Karin Kogermann, Ülo Maiväli, Marta Putrinš, all UT Institute of Technology. 
A new Swedish-Danish research alliance wants to advance understanding of how biological molecules look and behave. With support from the Knut and Alice Wallenberg Foundation and the Novo Nordisk Foundation, scientists at four universities in Sweden and Denmark will join forces to create a Nordic network in cryoelectron microscopy, whose developers were awarded the 2017 Nobel Prize in Chemistry.
Welcome to the Arctic Meeting on Clinical Tuberculosis, Umeå!
